Imunon, Inc. (CLSN) |
| 1.9466 -0.013 (-0.68%) 09-21 00:00 |
| Open: | 1.96 |
| High: | 1.99 |
| Low: | 1.9286 |
| Volume: | 56,809 |
| Market Cap: | 14(M) |
| PE Ratio: | -0.49 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.63 |
| Resistance 1: | 1.55 |
| Pivot price: | 1.51 |
| Support 1: | 1.43 |
| Support 2: | 1.19 |
| 52w High: | |
| 52w Low: |
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 09 Jul 2025
Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials - Clinical Leader
Thu, 22 May 2025
Imunon withdraws public offering registration - Investing.com
Tue, 20 Sep 2022
Celsion rebrands to Imunon to reflect immunotherapy, COVID-19 vaccine ambitions - Fierce Biotech
Mon, 19 Sep 2022
Celsion Corporation Announces Company Name Change to Imunon, Inc. - GlobeNewswire
Fri, 17 Sep 2021
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine - GlobeNewswire
Wed, 02 Jun 2021
Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021 - GlobeNewswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
